Oncology

Editor's Choice

Making good decisions requires that physicians have reliable and practical data. Comparative effectiveness reviews and objective findings on different medical interventions and strategies, as provided by the Agency for Healthcare Research and Quality in its Effective Health Care Program, can help physicians make the most informed choices among treatment options.

LATEST ARTICLES

Epidemiology data for melanoma serves up good, bad news

Although dermatologists may be disheartened by the latest melanoma epidemiology data showing continued rises in incidence and the annual number of melanoma-related deaths, recent advances in prevention, diagnosis and treatment should raise hope for the future, according to Darrell S. Rigel, M.D., who spoke at the 30th Annual Fall Clinical Dermatology Conference.

Photodynamic therapy increasingly valuable with ongoing experience

Accumulating experience with photodynamic therapy (PDT) has led to an expanding list of applications and new protocols that together have made PDT an increasingly valuable tool in the management of actinic keratosis (AK) and nonmelanoma skin cancer (NMSC).

Confounding factors may explain increasing skin cancer rates

Data suggest that proper sunscreen use can prevent melanoma and squamous cell carcinoma (SCC) and perhaps basal cell carcinoma (BCC), says Allan C. Halpern, M.D. However, he adds, confounding factors may explain the rising U.S. incidence rates of all skin cancers.

Effective Health Care Clinician Guides

FDA approves first licensed hematopoietic progenitor cells-cord cell therapy

FDA has approved Hemacord (New York Blood Center), the first licensed hematopoietic progenitor cells-cord cell therapy.